Live Breaking News & Updates on David schull

Stay informed with the latest breaking news from David schull on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in David schull and stay connected to the pulse of your community

BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024

BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Erik-kopp , Scott-stachowiak , Brennan-doyle , David-schull , While-the-company , Bioxcel-therapeutics-inc , Securities-exchange , Nasdaq , Abut-bioxcel-therapeutics-inc , Xcel-therapeutics , Report-first-quarter , Xcel-therapeutic

Registration for Association of Bioscience Financial Officers 2024 National Conference in May in Boston Nearing Full Capacity

Registration for Association of Bioscience Financial Officers 2024 National Conference in May in Boston Nearing Full Capacity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Solomon-wilcots , Jonathan-freve , David-schull , Kendalle-burlin-oconnell , Mike-mason , Maryellen-garrett , Tedy-bruschi , America-merrill-lynch , Capital-advisors-group

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholdersDALLAS, April 24, 2024 -- Spectral AI, Inc. , an artificial...

Dallas , Texas , United-states , Pete-carlson , David-schull , Conor-rodriguez , Devin-sullivan , Erich-spangenberg , Equity-group , Nasdaq , Spectral-ai-inc , Committee-of-the-board-directors

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states , Chicago , Illinois , American , Louism-weiner , Erik-kopp , Benjamin-weinberg , Scott-stachowiak , Brennan-doyle , David-schull , Drug-administration , Ruesch-center

Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call

Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Dallas , Texas , United-states , Devin-sullivan , Conor-rodriguez , David-schull , Nasdaq , Spectral-ai-inc , Equity-group , Quarter-financial-results , Eastern-time , Investor-relations

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

22.04.2024 - The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ETCORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage ...

Canada , United-states , America , David-schull , Mary-coleman , Catalyst-pharmaceuticals-inc , Exchange-commission , Health-canada , About-catalyst-pharmaceuticals , North-america , Duchenne-muscular , Fast-track

Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer

Experienced Burn Industry Executive Champions Pivot to CommercializationDALLAS, April 01, 2024 -- Spectral AI, Inc. , an artificial intelligence company focused on medical diagnostics for faster...

Dallas , Texas , United-states , David-schull , Devin-sullivan , Conor-rodriguez , Peterm-carlson , International-relations , Nasdaq , Health-economics , Allergan , Thunderbird-graduate-school-of-global-management

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium

CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living

Canada , United-states , America , Richardj-daly , Mary-coleman , David-schull , Health-canada , Catalyst-pharmaceuticals , Exchange-commission , Catalyst-pharmaceuticals-inc , Virtual-muscular-dystrophy-symposium , North-america

Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results

2023 Research & Development Revenue of $18.1 Million Expected to Increase to $28.0 Million in 2024 Commercialization Underway with Revenue Expected in 2H 2024 for DeepView AI®-Burn Indication in...

United-states , Dallas , Texas , United-kingdom , Conor-rodriguez , J-michael-dimaio , Deepak-sadagopan , Paul-chadwick , Devin-sullivan , Peterm-carlson , David-schull , Erich-spangenberg